DarioHealth (DRIO) to Release Quarterly Earnings on Thursday

DarioHealth (NASDAQ:DRIO) is expected to be releasing its earnings data before the market opens on Thursday, March 27th. Analysts expect DarioHealth to post earnings of ($0.24) per share and revenue of $7.39 million for the quarter. Persons interested in registering for the company’s earnings conference call can do so using this link.

DarioHealth Stock Performance

Shares of NASDAQ:DRIO opened at $0.66 on Wednesday. DarioHealth has a 1 year low of $0.56 and a 1 year high of $1.93. The stock has a market capitalization of $27.59 million, a price-to-earnings ratio of -0.71 and a beta of 1.42. The company has a debt-to-equity ratio of 0.35, a current ratio of 1.57 and a quick ratio of 1.32. The company’s 50 day simple moving average is $0.68 and its 200 day simple moving average is $0.81.

Wall Street Analyst Weigh In

Several equities analysts have recently issued reports on DRIO shares. Stifel Nicolaus decreased their price target on DarioHealth from $3.50 to $2.00 and set a “buy” rating on the stock in a research note on Tuesday, March 11th. TD Cowen cut DarioHealth from a “buy” rating to a “hold” rating and decreased their target price for the company from $2.00 to $1.00 in a research report on Wednesday, January 29th.

About DarioHealth

DarioHealth Corp. operates as a digital health company in the United States, Canada, the European Union, Australia, and New Zealand. Its digital therapeutics platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health.